Stay updated with breaking news from Marcelav Maus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The next evolution of gene therapies may involve pitting T cells with different modifications against one another in a “race” inside a human to determine which edits produce the best results against a tumor, an expert panel predicted. Researchers across the globe have discovered dozens of genes that could be targeted to make T cells more durable and effective in tumor
:max_bytes(150000):strip_icc():focal(749x0:751x2)/cancer-cells-tout-113023-5d43032109dc463fa7a9fc490a7342f2.jpg)
The FDA announced that certain CAR-T treatments for blood cancer have been linked to the development of other cancers.
The agency is looking into reports that some patients developed new blood cancers after receiving CAR-T treatments.
Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To "Avidity Enhancement" AMSTERDAM, May 24, 2022 /PRNewswire/ -- LUMICKS, a leading
/PRNewswire/ -- LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced...